Update on MS research

Similar documents
Stem cells and motor neurone disease


STEM CELL FACTS. The ISSCR is an independent, nonproft organization providing a global forum for stem cell research and regenerative medicine.

The Prospect of Stem Cell Therapy in Multiple Sclerosis. Multiple sclerosis is a multifocal inflammatory disease of the central

5 Frequently Asked Questions About Adult Stem Cell Research

Stem cells and motor neurone disease

Understanding How Existing and Emerging MS Therapies Work

Patient Handbook on Stem Cell Therapies

It s not something you want to think about, but it s something you want to prepare for.

Stem Cell Quick Guide: Stem Cell Basics

San Diego Stem Cell Treatment Center Frequently Asked Questions

CURRENT STATUS OF STEM CELL TREATMENTS FOR CEREBRAL PALSY: A GUIDE FOR PATIENTS, FAMILIES AND CAREGIVERS

The Types of stem cells: Totipotent Pluripotent Multipotent

Top Ten Things to Know About Stem Cell Treatments

STEM CELL FELLOWSHIP

Introducing stem cells

Stem cell research ACADEMY STATEMENT. progress, hopes and concerns ACADEMY STATEMENT 16 JANUARY 2013

New research in primary and secondary progressive multiple sclerosis. Dr Claire McCarthy MRCP PhD Neurology SpR Addenbrooke s Hospital

Stem cells possess 2 main characteristics: Sources of pluripotent stem cells: -Long-term self renewal. -The inner cell mass of the blastocyst.

Introducing stem cells Stem cells in the news

For a full list of MS Trust publications, to sign up for Open Door and much more visit our website at

Research: Stem Cells. What are Stem Cells?

15 Stem Cell Research

Recruitment Start date: April 2010 End date: Recruitment will continue until enrolment is fully completed

Stem Cell Research: Adult or Somatic Stem Cells

Stem Cell Information

Policy statement. Stem cell research

FastTest. You ve read the book now test yourself

tem ells /background /information Stem cell research Copyright 2007 MRC Centre for Regenerative Medicine, Institute for Stem Cell Research

New Treatment Options for MS Patients: Understanding risks versus benefits

Stem Cells and Inner Ear Cell Regeneration. Stefan Heller Stanford University School of Medicine

Stem Cell Therapy Applications in pediatric neurology

Roche Position on Human Stem Cells

Differentiation = Making specialized cells. Your body needs stem cells. What is a stem cell?

Briefing on the second reading of the Human Fertilisation and Embryology Bill, Monday 19 November 2007.

THE PROMISE OF STEM CELL RESEARCH

An Introduction to Stem Cell Biology. Michael L. Shelanski, MD,PhD Professor of Pathology and Cell Biology Columbia University

guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research

An Introduction to Stem Cells

Background Information

Multiple Sclerosis in Practice. An Expert Commentary With Jeffrey Cohen, MD, PhD A Clinical Context Report

Stem Cells and Hope for Patients

What are Stem Cells? How can they be used in medicine?

Chapter 16 Reproductive Technology, Gene Therapy, and Stem Cells (modified)

Disclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics

Novel therapeutic approaches in multiple sclerosis Neuroprotective and remyelinating agents, the future of clinical trials in MS?

Biotechnology. Srivatsan Kidambi, Ph.D.

THE FUTURE OF STEM CELLS IN MEDICINE BY AGNES MILNER KATIE CLARK. Pass with Merit

IF YOU ARE RECEIVING TREATMENT WITH TYSABRI FOR RELAPSING-REMITTING MS (NATALIZUMAB)

International Stem Cell Registry

Stem Cells: Scientific Progress and Future Research Directions

CONSULTATION RESPONSE

Multiple Sclerosis. Matt Hulvey BL A - 615

Slide 1: Preparation Before the school visit At the school

Stem Cell Therapies: Now and in the Future The Australian Stem Cell Centre Patient Handbook

Collaborative Network Award Planning Grants Project Summaries

Demystifying Stem Cells. Brent Bost M.D., CPA, MBA, FACOG

Differentiation = Making specialized cells

Spinal cord injury Copyright 2007 MRC Centre for Regenerative Medicine, Institute for Stem Cell Research

Autoimmunity. Autoimmunity. Genetic Contributions to Autoimmunity. Targets of Autoimmunity

Saving Cord Tissue for Your Family

Programa Cooperación Farma-Biotech Neurociencias NT-KO-003

MS Treatments Aubagio TM

Should Stem Cells Be Used To Treat Human Diseases?

The ethics of stem cell research and treatment

Clinical Trials of Disease Modifying Treatments

Stem Cells. Part 1: What is a Stem Cell?

Multiple Sclerosis Update. Bridget A. Bagert, MD, MPH Director, Ochsner Multiple Sclerosis Center

Progress in MS: Current and Emerging Therapies

MS Treatments Gilenya

Stem Cell Therapy & Multiple Sclerosis. Bernhard H.J. Juurlink 1 Professor emeritus, Department of Anatomy & Cell Biology University of Saskatchewan

A Genetic Analysis of Rheumatoid Arthritis

Disease Modifying Therapies for MS

Edited by contributors: Jan Barfoot, Donald Bruce, Graeme Laurie, Nina Bauer, Janet Paterson and Mary Bownes. Stem Cells. science and ethics

Stem cell research and Parkinson's

Recent Multiple Sclerosis (MS)

Stem cell therapies in MS

Chapter 2 The different types of stem cells

STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE

MS CLINIC NEWSLETTER London Health Sciences Centre - University Hospital

Save up to 25% off stem cell banking with Netcells Biosciences

A STRONG DECISION FOR A HEALTHY FUTURE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal

THE SPINAL CORD AND THE INFLUENCE OF ITS DAMAGE ON THE HUMAN BODY

Focus on CNS Drug Development Treating secondary progressive multiple sclerosis. Simon Wilkinson, CEO

Natalizumab (Tysabri)

Unit 1 Higher Human Biology Summary Notes

MS in focus. Stem cells and Remyelination in MS. The Magazine of the Multiple Sclerosis International Federation. Issue

AAGPs TM Anti-Aging Glyco Peptides. Enhancing Cell, Tissue and Organ Integrity Molecular and biological attributes of lead AAGP molecule

the future in your hands imagine

Treatments for MS: Immunotherapy. Gilenya (fingolimod) Glatiramer acetate (Copaxone )

News on modifying diseases therapies. Michel CLANET CHU Toulouse France ECTRIMS

My MS prog-blog. The ezine for people with progressive MS Issue 2, June/ July 2015

House of Lords Select Committee on Science and Technology: Regenerative Medicine

An introduction to modern MS treatments

Stem Cell Research. Debate motion

Guidance For Research Involving Human Embryonic Stem Cells, Germ Cells, And Cells Obtained From Cord Blood

Understanding. Multiple Sclerosis. Tim, diagnosed in 2004.

Understanding your Tecfidera treatment

Understanding your Tecfidera treatment

Transcription:

Update on MS research Anna Williams Scottish Senior Research Fellow and Honorary Consultant Neurologist

Plan Where do we do MS research in Edinburgh? What is missing in MS therapy? 2 ways to improve brain repair in MS using our own stem cells Making stem cells from MS patients

Scottish Centre for Regenerative Medicine

Project Base - Edinburgh MRC Scottish Centre for Regenerative Medicine 230 Researchers No 9, Bioincubator MRC hub for Stem cell niche - 5.6 million Medical School 250 Researchers Anne Rowling Regenerative Neurology Clinic 1700 MS patients. 1/500 in Scotland Royal Infirmary 870 beds Clinical Research Facility MHRA Accredited Phase 1 Unit Clinical Research Imaging Centre Queen s Medical Research Institute 650 Researchers Drug Discovery Core 4

What is MS? Immune attack Oligodendrocyte precursor cells to remyelinate Neural protection

MS therapy disability Inflammation neurodegeneration βifn, Fingolimod, Natalizumab, Teriflunomide, fumarate, Alemtuzumab Relapses Progression time Anti-inflammatory drugs Neuroprotective therapies

Neuroprotective strategies 8 Demyelination Axon degeneration Promote axon survival as in MND, AD, stroke etc. Remyelination (inefficient)

What is required for remyelination? Demyelination Remyelination Oligodendrocyte Precursor Cell Recruitment Maturation

Causes of remyelination failure in MS Failure of OPC recruitment 40% 60% Successful OPC recruitment Failure of OPC maturation Remyelination failure

Semaphorin action on OPCs in MS? Chronic demyelination Sema 3A Repulsive

No. of OPCs in lesion Some human MS lesions have few OPCs and more Sema3A No. of Sema3A+ cells/area Sema3A 400 35 30 *** 300 200 100 25 20 15 10 5 Active 0 Repairing Active hronic Inactive Not repairing Remyelinated Chronic Active Normal Control hronic Inactive Remyelinated 0 Control Active Repairing Chronic Not active repairing Normal Normal Boyd A, Zhang H, Williams A. 2013

Experimental plan Look at remyelination after 2 and 3 weeks

% fibres remyelinated Decreased Sema3AIncreased Sema3A Evidence that manipulation of Sema3A alters remyelination 100 2 weeks 3 weeks 90 80 70 60 50 40 30 Control Sema3A Sema3AKD More Sema3A Less OPCs Less remyelinated fibres 20 10 0 2 weeks 3 weeks 4 weeks Time after demyelination Less Sema3A More OPCs More remyelinated fibres (data from 3 independent labs)

Target Block OPC response to Sema3A through receptor Neuropilin1 to improve recruitment and remyelination 16

Causes of remyelination failure in MS Failure of OPC recruitment 40% 60% Successful OPC recruitment Failure of OPC maturation Remyelination failure Remyelination success

Remyelination is improved by 9cRA Normalised Myelination Index Huang, Jarjour..Williams.ffrench-Constant, Franklin. 2011 Nature Neuroscience Myelin/ Nerves blockers Control 9cRA HX531 PA452 2.5 2 1.5 1 0.5 0

Other molecules involved

Timelines Discovery of LINGO Inhibiting O maturation 2004 blocking antibodies promoting rodent CNS remyelination 2007 Phase 1 trial 2012 Phase 2 trial 2014 RXRg agonists aid remyelination 2011 Grant to develop drugs?2015 Sema3A/NP1 inhibits remyelination 2013 Grant to develop drug inhibitors 2015

A stem cell can self-renew or differentiate stem cell DIFFERENTIATION (specialising) specialised cell e.g. muscle cell, nerve cell SELF-RENEWAL (copying) stem cell grow repair renew

Different types of stem cells Tissue stem cells Embryonic stem cells Induced pluripotent stem cells Throughout life Blastocyst Cell from the body Pluripotent cell Inner cell mass Genetically reprogrammed

What is a stem cell? Pluripotent Induced pluripotent (embryonic) stem stem cell cell Neural stem cell Gut stem cell Blood stem cell Skin stem cell Cardiac stem cell Mesenchymal stem cell? Nerve Oligodendrocyte Immune cell Skin cell Bone Cartilage Fat

How to make an ips cell? ES cells Oct4 c-myc Klf4 Sox2 Skin fibroblasts ips cells Takahashi K, Yamanaka S. Cell. 2006 Aug 25;126(4):663-76.

ips cells In theory, from any cell, to make any cell Person specific compatibility/disease lines (drug testing, understanding biology) Ethically easier

Regrowing the brain? Myelin repair Nerve replacement Can grow human nerves and myelin in culture dish Not feasible at present in people

Multiple lesions Problems How do we get stem cells in? New lesions Can they migrate? Where do we get them from? Some lesions repair themselves Danger operations, drugs, infection, tumours How will they know what connections to make?

Spinal cord injury How do we get stem cells in? One lesion Can they migrate? Where do we get them from? No new lesions Very little repair How will they know what connections to make? Danger operations, drugs, infection, tumours

I will take any risks I want to be a guinea pig for stem cells We have collected thousands of pounds to get stem cell treatment I want stem cells for my MS Why won t the NHS give me stem cells? It is a conspiracy to keep Drs and drug companies in a job

Stem cell tourism Put stem cell and MS into Google get over 1 million hits STEM CELLS FOR HOPE

Counter culture Stem Cell Fraud: A 60 Minutes investigation Stem cells in Texas: Cowboy culture Researchers Highlight Warning Signs On Adult Stem Cell Treatments Stem cell hype and the dangers of stem cell tourism STEM CELL TOURISM: SEEKING TREATMENT ON THE INTERNET AND PAYING FOR IT WITH YOUR LIFE While there are some very promising results... the treatments being advertised by these clinics are dubious, mostly ineffective, and sometimes positively harmful. Alta Charo Stem cell tourism growing trend Desperate patients warned to avoid stem Panel decries overseas clinics that provide cell tourism abroad over unproven 'miracle' treatments devoid of scientific validity claims

How do we compete? In short I ve got my life back my kids have their dad back and my wife has the man she knew before this terrible disease changed our lives. "We decided... through endless hours of discussion that this is the best investment we can make to improve both our lives We're always just waiting in hope. Stem cells have become a magic word. Often new areas of science get that reputation; in the 19th century. everything with electricity or magnetism was magic. Today it's stem cells and nanotechnology. It is time to lose the hype without losing the hope."

It s nothing a few stem cells and another 75 years of research won t fix

EBV, chlamydia, coxsackie, canine distemper virus, HHV6, Clostridium What causes MS? Young 2F:1M GWAS HLA DR2, others in immune system 1 in 500 in Scotland Twin studies 30% MZ Genetic Immune Position of plaques Latitude and vitamin D Infective